Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pathologic Complete Response × Radiation × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 44 Glioblastoma 43 Breast Neoplasms 38 Esophageal Neoplasms 31 Carcinoma, Non-Small-Cell Lung 30 Rectal Neoplasms 29 Lung Neoplasms 29 Head and Neck Neoplasms 27 Squamous Cell Carcinoma of Head and Neck 24 Pancreatic Neoplasms 19 Brain Neoplasms 19 Uterine Cervical Neoplasms 16 Neoplasms 16 Neoplasm Metastasis 15 Gliosarcoma 15 Esophageal Squamous Cell Carcinoma 15 Oropharyngeal Neoplasms 14 Sarcoma 13 Melanoma 13 Glioma 13 Adenocarcinoma Of Esophagus 11 Stomach Neoplasms 10 Carcinoma, Squamous Cell 9 Lymphoma, Follicular 8 Mouth Neoplasms 7 Lymphoma, B-Cell, Marginal Zone 7 Leukemia, Myeloid, Acute 7 Endometrial Neoplasms 7 Astrocytoma 7 Anus Neoplasms 7

Interventions

Trastuzumab 4 Oxaliplatin 4 Fluorouracil 4 Cyclophosphamide 4 pembrolizumab 3 Radiotherapy 3 Paclitaxel 3 Endoscopy 3 Docetaxel 3 Cytarabine 3 Chemoradiotherapy 3 Carboplatin 3 Capecitabine 3 Surgical Procedures, Operative 2 Standard of Care 2 Observation 2 Metformin 2 Magnetic Resonance Imaging 2 Leucovorin 2 Irinotecan 2 Immunotherapy 2 Immune Checkpoint Inhibitors 2 Epirubicin 2 Drug Therapy 2 Doxorubicin 2 Cisplatin 2 Blood Specimen Collection 2 zanidatamab 1 venetoclax 1 veliparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡